Tags: Drug.

Telaprevir (VX-950) marketed under the brand names Incivek and Incivo is a pharmaceutical drug for the treatment of hepatitis C co-developed by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors. Specifically telaprevir inhibits the hepatitis C viral enzyme NS3.4A serine protease.

Telaprevir.svg
ATC prefix
J05
ATC suffix
AE11
CAS number
402957-28-2
ChEBI
68595
FDA UNII code
655M5O3W0U
IUPAC name
(1S3aR6aS)-2-[(2S)-2-[[(2S)-2-Cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-33-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-12-dioxohexan-3-yl]-33a4566a-hexahydro-1H-cyclopenta[c]pyrrole-1-carboxamide
PubChem
3010818

Loading...

This page contains content from the copyrighted Wikipedia article "Telaprevir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.